Polpharma Pharmaceutical Works - API Manufacturer

drukuj

World class service   

Polpharma provides a one-stop shopping solution of integrated services ranging from API development

to finished dosage formulation and scale-up capabilities based on in-house or customer developed technology and the support of the registration file.

 

Full support from molecule development to drug delivery


We offer:

  • Development, production and marketing of generic APIs
  • Custom synthesis and toll manufacturing
  • Intellectual Property review services
  • Non-infringing process development
  • US and European DMFs in a common format
  • Wide reaction classes in FDA approved facilities
  • Multipurpose production lines
  • High GMP standards
  • Product quality

 

Cost-effective solutions tailored to the customers` needs

We constantly seek ways to add value to everything that we do for our customers. We ensure to keep our API portfolio updated and expand it with new, attractive compounds.

Our cGMP capacity combined with a short development time and competitive pricing make us a natural choice for pharmaceutical companies interested in outsourcing their manufacturing activities. We have gained an exceptional reputation among our customers worldwide for the quality of our contract manufacturing services.

 

Out-licensing offer

Our services include EU standard dossiers for finished dosage formulations based on APIs developed in-house or sourced externally. Our out-licensing portfolio secures the most comprehensive offer for our clients.

 

Quality, optimization and customer satisfaction are the driving forces behind our work

Our products are manufactured in accordance with the most stringent requirements of our customers and health authorities. DMF documentation for all our products is prepared in accordance with the latest requirements of EDQM (CEP), ICH (EuDMF, CTD), and FDA (US DMF).

Material and product testing is performed according to the European and United States Pharmacopeias. However, our products can be additionally tested in compliance with the customer’s specifications.

Latest news

Successful GMP audit by Japanese companies

Thursday, 01-07-2010
Polpharma Fine Chemicals Business Unit passed successfully inspection by two of the major generic Japanese...

EU DMF for Solifenacin succinate available

Wednesday, 12-05-2010
EU DMF documentation in eCTD format for Solifenacin succinate manufactured by Polpharma Fine Chemicals...

Polpharma recognised for investing in research and development

Tuesday, 04-05-2010
Polpharma reached the top leaders of the ranking of the largest investors in research and development in...

Process Excellence Award

Wednesday, 28-04-2010
Polpharma was ranked among the first three companies in the “Green Process Award”, of the 11th...
Copyright © 2009 Polpharma S.A. All rights reserved.
Realizacja: Ideo Powered by : EditoCMS